Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Invest Radiol. 2015 Dec;50(12):821–827. doi: 10.1097/RLI.0000000000000190

Table 2.

a: Controls Baseline vs. Post-furosemide R2*
Region Baseline R2* (s−1) Post R2* (s−1) P-value d
Large Cortex 19.6 ± 3.6 18.7 ± 4.7 0.22 0.21
Medulla 30.9 ± 4.1 22.5 ± 5.0 0.002 1.59
Parenchyma 23.8 ± 2.7 20.6 ± 4.1 0.002 0.84
b: CKD Baseline vs. Post-furosemide R2*
Region Baseline R2* (s−1) Post R2* (s−1) P-value d
Large Cortex 23.9 ± 7.3 22.0 ± 6.9 0.056 0.22
Medulla 29.7 ± 7.2 26.7 ± 7.0 0.039 0.35
Parenchyma 26.3 ± 6.1 24.8 ± 5.6 0.004 0.21

Wilcoxon signed rank test statistic

Cohen’s d measure of effect size